
About Peptomer Therapeutics
Peptomer Therapeutics is a Healthcare company based in United Kingdom founded in 2020. Provider of drug development services for antimicrobial peptides and oligomers. The company has 1 employees. Its Indian entity Peptomer Therapeutics Private Limited reported revenue of βΉ33.8 Lakh. Peptomer Therapeutics offers products and services including Oligomers, Peptides, and Oligomer-Peptide Hybrids. Its focus areas include Biopharma Outsourcing, CDMO, Small Molecules & Peptides and Drug Development.
Company details
Peptomer Therapeutics provider of drug development services for antimicrobial peptides and oligomers, focusing on providing healthcare solutions, biopharma outsourcing, cdmo, small molecules peptides, drug development, and peptide. It serves clients with dedicated solutions, emphasizing quality, innovation, and sustainable growth in its core markets.
- Headquarters United Kingdom
- Employees 1
- SectorsHealthcare
- Website peptomertherapeutics.com
- Social LinkedIn X Facebook
- Legal Name Peptomer Therapeutics Private Limited
- Date of Incorporation 10 Jul, 2020
- Jurisdiction Delhi, India
- Indian entity revenue₹33.8 Lakh
FY 2024 · +58% YoY
- Indian entity net loss-₹16.4 Lakh
FY 2024 · -48% margin
- Indian entity EBITDA-₹14.5 Lakh
FY 2024 · -43% margin
- Employee Count1
Associated legal entities of Peptomer Therapeutics
Peptomer Therapeutics operates through Peptomer Therapeutics Private Limited (active). Its filings, financials, charges and directors are on the company page.
| Legal entity | Status | Incorporated | Registered in | Revenue (FY 2024) | Employees | Directors | Company page |
|---|---|---|---|---|---|---|---|
| Peptomer Therapeutics Private Limited CIN U24110DL2020PTC365923 | Active | 10 Jul 2020 | Delhi, Delhi | ₹0.3 Cr | 2 | View details |
Products & Services of Peptomer Therapeutics
Peptomer Therapeutics offers a comprehensive portfolio of products and services, including Oligomers, Peptides, and Oligomer-Peptide Hybrids.
Compounds effective against multi-drug resistant bacteria.
Peptidomimetics with broad-spectrum activity against pathogens.
New hybrids targeting bacteria and fungi for AMR solutions.
Board of directors of Peptomer Therapeutics Private Limited (Peptomer Therapeutics)
Peptomer Therapeutics Private Limited is the primary company behind Peptomer Therapeutics. The board of Peptomer Therapeutics Private Limited currently have 2 directors; the longest-serving is Manohar Mahato, appointed in 2020.
| Director | Designation | Appointed | Tenure | Entity |
|---|---|---|---|---|
| Manohar Mahato DIN 08606928 | Director | 10 Jul 2020 | 6 yrs 4 mo | Peptomer Therapeutics Private Limited |
| Kantaraja Chindera DIN 08788381 | Director | 10 Jul 2020 | 6 yrs 4 mo | Peptomer Therapeutics Private Limited |
Financials of Peptomer Therapeutics
Figures of Peptomer Therapeutics Private Limited, the primary company behind Peptomer Therapeutics, for FY 2024. Revenue was ₹33.8 Lakh (+58% year on year). Net loss was -₹16.4 Lakh (-48% margin). EBITDA was -₹14.5 Lakh (-43% margin).
- ₹33.8 LakhRevenue · FY 2024 · +58% YoY
- -₹16.4 LakhNet loss · -48% margin
- -₹14.5 LakhEBITDA · -43% margin
- ₹5 LakhPaid-up capital
Balance sheet, profit and loss, cash flow and ratios of Peptomer Therapeutics Private Limited are on its company page.
Detailed financial statements for Peptomer Therapeutics
Statement rows, ratios, five-year trends and downloadable financials of the group companies require an active premium plan.
- Statement rows
- Financial ratios
- Five-year trends
- Downloads
Verified entity values are shown only after access is granted.
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track β from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Frequently Asked Questions about Peptomer Therapeutics
Peptomer Therapeutics was founded in 2020.
Peptomer Therapeutics is headquartered in United Kingdom.
Peptomer Therapeutics has 1 employees.
The primary company behind Peptomer Therapeutics, Peptomer Therapeutics Private Limited, reported revenue of βΉ33.8 Lakh for FY 2024, up 58% year on year.
Peptomer Therapeutics provider of drug development services for antimicrobial peptides and oligomers, focusing on providing healthcare solutions, biopharma outsourcing, cdmo, small molecules peptides, drug development, and peptide. It serves clients with dedicated solutions, emphasizing quality, innovation, and sustainable growth in its core markets.
Peptomer Therapeutics offers Oligomers, Peptides, and Oligomer-Peptide Hybrids.
Peptomer Therapeutics operates through Peptomer Therapeutics Private Limited.
The legal entities of Peptomer Therapeutics currently have 2 directors, including Manohar Mahato, Kantaraja Chindera.